MedicaidPrior AuthMedium impact
Newsletter Vol. 10, No. 60
New Jersey Medicaid·NJ · Endocrinology, Pediatrics, Family Medicine·Provider Notice
We identified it
Jun 20, 2026
Summary
New Prior Drug Utilization Review (PDUR) standards have been established for Somatropin (growth hormone) prescriptions. This policy likely introduces new prior authorization requirements, dosing guidelines, or coverage criteria for growth hormone medications that will affect billing and approval processes.
Action Required
Immediately: Review the full policy document at https://www.njmmis.com/documentDownload.aspx?document=10-60.pdf to understand new Somatropin PDUR requirements. Billing team and providers must identify specific prior authorization changes, documentation requirements, and coverage criteria. Update prior authorization workflows and inform providers of any new prescribing guidelines to prevent claim denials.